- Home
- CLOV vs INVA Comparison
CLOV vs INVA Comparison
Compare CLOV & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLOV | INVA |
|---|---|---|
| Founded | 2014 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 2020 | 2000 |
Fundamental Metrics
Financial Performance| Metric | CLOV | INVA |
|---|---|---|
| Price | $4.80 | $22.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | $2.90 | ★ $32.80 |
| AVG Volume (30 Days) | ★ 8.1M | 763.3K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 38.03 | ★ 816.67 |
| EPS | 0.05 | ★ 2.22 |
| Revenue | ★ $1,924,308,000.00 | $217,217,000.00 |
| Revenue This Year | $52.59 | $8.95 |
| Revenue Next Year | $15.37 | $12.65 |
| P/E Ratio | $85.80 | ★ $10.15 |
| Revenue Growth | 40.34 | ★ 62.63 |
| 52 Week Low | $1.58 | $16.52 |
| 52 Week High | $4.44 | $25.15 |
Technical Indicators
Market Signals| Indicator | CLOV | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 76.36 | 57.55 |
| Support Level | $1.96 | $21.45 |
| Resistance Level | N/A | $24.22 |
| Average True Range (ATR) | 0.27 | 0.55 |
| MACD | 0.04 | 0.14 |
| Stochastic Oscillator | 77.81 | 84.13 |
Price Performance
Historical ComparisonAbout CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.